Jounce
Hospitality · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
39 Harding Ave, Clifton, New Jersey, 070...Website
www.jounce.orgRevenue
<$5 MillionIndustry
About Jounce
Jounce Org Chart
Is Jounce your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Jounce has new funding data
Congratulate Masked Content for being promoted to Masked Content at Jounce
Check if Jounce has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Jounce launches new products
Jounce, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Jounce recently announced quarterly report
Check out if Jounce is spiking on competitors!
Click to see if Jounce had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Jounce
Find 3 more new buyers
Compare Similar Companies to Jounce
Compare insights from companies similar to Jounce, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Jounce is experiencing very low activity levels compared to other companies in the Hospitality sector.
What does this means?
Jounce is drawing exceptional interest within the Hospitality industry, suggesting notable developments or strong market momentum, learn more about Jounce.
Jounce Tech Stack
A closer look at the technologies used by Jounce
Jounce News & Media
Jounce Therapeutics Announces Proposed Offering of Common Stock
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it is offering to sell shares of its common stock in an underwritten public offering.Jounce Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
- Commenced enrollment in both the Phase 1 INNATE trial of JTX-8064 (LILRB2 / ILT4) and the Phase 2 SELECT trial of Vopratelimab in combination with JTX-4014 -Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment of Luisa Salter-Cid, Ph.D., to its board of directors.Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and...
Top Hospitality Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jounce
Home page of Jounce, an alternative group from Brooklyn, NY. Jounce, an East to West Coast staple, is an evolving post punk rock band. Their dedication to writing good tunes creates an energetic, yet, laid back atmosphere during their live performance... Read More